MedTrace Logo

RWE-based Treatment Patterns and Outcomes in CIDP

NCT05940922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2023-07-11

No results posted yet for this study

Summary

To describe the demographics, clinical characteristics, treatment patterns and clinical outcomes of chronic inflammatory demyelinating polyneuropathy (CIDP), Guillain-Barre Syndrome (GBS), and heredofamilial amyloidosis (hATTR) adult patients at a single U.K. centre.

Conditions

Interventions

OTHER

No intervention. Retrospective observation only.

No intervention. Retrospective observation only.

Sponsors & Collaborators

  • Alnylam Pharmaceuticals

    collaborator INDUSTRY

  • Northern Care Alliance NHS Foundation Trust

    collaborator OTHER

  • RwHealth

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-17
Primary Completion
2023-10-30
Completion
2023-10-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05940922 on ClinicalTrials.gov